Research on protective mechanism of ibuprofen in myocardial ischemia-reperfusion injury in rats through the PI3K/Akt/mTOR signaling pathway

被引:11
|
作者
Chi, Y. [1 ]
Ma, Q. [2 ]
Ding, X-Q [3 ]
Qin, X. [4 ]
Wang, C. [5 ]
Zhang, J. [6 ]
机构
[1] Jining Med Univ, Peoples Hosp Rizhao, Community 1, Rizhao, Peoples R China
[2] Jining Med Univ, Peoples Hosp Rizhao, Dept Cardiovasc Med, Rizhao, Peoples R China
[3] Rizhao Inst Prevent & Control TB, Rizhao, Peoples R China
[4] Jining Med Univ, Peoples Hosp Rizhao, Dept Neurol, Rizhao, Peoples R China
[5] Jining Med Univ, Peoples Hosp Rizhao, CT Room, Rizhao, Peoples R China
[6] Jining Med Univ, Peoples Hosp Rizhao, Dept Cardiothorac Vasc Surg, Rizhao, Peoples R China
关键词
Ibuprofen; Myocardial ischemia-reperfusion; PI3K/Akt/mTOR signaling pathway; APOPTOSIS;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To study the protective mechanism of ibuprofen (Ib) in myocardial ischemia-reperfusion (I/R) injury in rats, and to analyze its regulatory effect on the phosphatidylinositol 3-hydroxy kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathway. MATERIALS AND METHODS: The rat model of myocardial I/R injury was established via ligation of the left main coronary artery (LCA) for 30 min and then reperfusion for 120 min. A total of 36 Sprague-Dawley (SD) rats were randomly divided into sham group (S group, n=12), model group (I/R group, n=12) and lb group (n=12). The levels of serum creatine kinase-MB (CK-MB) and lactate dehydrogenase (LDH) in each group were detected. The rats were executed, the heart was isolated and the area of myocardial infarction was determined via 2,3,5-triphenyltetrazolium chloride (TTC) staining. The expression levels of vascular endothelial growth factor (VEGF), hypoxia-inducible factor 1 (HIF-1) and apoptosis-related proteins in myocardial tissues in each group were detected via Western blotting. Moreover, the content of inflammatory factors in myocardial tissues in each group was detected using the enzyme-linked immunosorbent assay (ELISA) kit. The expression levels of related proteins in the PI3K/Akt/mTOR signaling pathway in myocardial tissues were further analyzed. RESULTS: Compared with those in S group, the levels of CK-MB and LDH were significantly increased (p<0.01), the area of myocardial infarction was significantly increased (p<0.01), the VEGF, HIF-1 and Cleaved caspase-3 protein levels in myocardial tissues were increased (p<0.01), while Bcl-2/Bax declined (p<0.01), the content of interleukin-1 (IL-1), IL-6 and tumor necrosis factor-alpha (TNF-alpha) in myocardial tissues was increased (p<0.01), while the content of IL- 10 declined (p<0.01), and the expression levels of PI3K, p-Akt and p-mTOR proteins in myocardial tissues were significantly decreased (p<0.01) in I/R group. Compared with those in I/R group, the levels of CK-MB and LDH were significantly decreased (p<0.01), the area of myocardial infarction was significantly decreased (p<0.01), the VEGF, HIF-1 and Cleaved caspase-3 protein levels in myocardial tissues were decreased (p<0.01), while Bcl-2/Bax was increased (p<0.01), the content of IL-1, IL-6 and TNF-alpha in myocardial tissues declined (p<0.01), while the content of IL-10 was significantly increased (p<0.01), and the expression levels of PI3K, p-Akt and p-mTOR proteins in myocardial tissues were significantly increased (p<0.01) in Ib group. CONCLUSIONS: Ib can activate the PI3K/Akt/mTOR signaling pathway, reduce the release of inflammatory factors and apoptosis, and alleviate the myocardial I/R injury in myocardial cells in rats.
引用
收藏
页码:4465 / 4473
页数:9
相关论文
共 50 条
  • [21] Dexmedetomidine alleviates lung ischemia-reperfusion injury in rats by activating PI3K/Akt pathway
    Liang, S.
    Wang, Y.
    Liu, Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (01) : 370 - 377
  • [22] Astragaloside IV alleviates myocardial ischemia-reperfusion injury in rats through regulating PI3K/AKT/GSK-3β signaling pathways
    Wei, Dajun
    Xu, Hongjie
    Gai, Xiaodong
    Jiang, Ying
    ACTA CIRURGICA BRASILEIRA, 2019, 34 (07)
  • [23] LncRNA MALAT1 knockdown alleviates myocardial apoptosis in rats with myocardial ischemia-reperfusion through activating PI3K/AKT signaling pathway
    Sun, T.
    Cheng, Y-T
    Yan, L-X
    Krittanawong, C.
    Qian, W.
    Zhang, H-J
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (23) : 10523 - 10531
  • [24] Gomisin N attenuated cerebral ischemia-reperfusion injury through inhibition of autophagy by activating the PI3K/AKT/mTOR pathway
    Li, Ruoqi
    Zheng, Yingyi
    Zhang, Jiaxue
    Zhou, Yuan
    Fan, Xiang
    PHYTOMEDICINE, 2023, 110
  • [25] Protective Effects of Propofol on Rats with Cerebral Ischemia–Reperfusion Injury Via the PI3K/Akt Pathway
    Yaru Chen
    Zhenzhou Li
    Journal of Molecular Neuroscience, 2021, 71 : 810 - 820
  • [26] Sevoflurane Alleviates Myocardial Ischemia-Reperfusion Injury in Rats by Reducing Oxidative Stress and Activating PI3K/Akt/GSK3β Signaling Pathway
    Zhang, Zhengbing
    Luo, Chunfang
    Wan, Caiyun
    Xu, Kai
    Huang, Fang
    Feng, Yinghui
    Li, Ming
    Min, Wei
    LATIN AMERICAN JOURNAL OF PHARMACY, 2020, 39 (02): : 394 - 400
  • [27] Piperine protects against myocardial ischemia/reperfusion injury by activating the PI3K/AKT signaling pathway
    Li, Yun-Peng
    Chen, Zhen
    Cai, Yu-Hua
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (04)
  • [28] Natural compounds regulate the PI3K/Akt/GSK3β pathway in myocardial ischemia-reperfusion injury
    Ajzashokouhi, Amir Hossein
    Rezaee, Ramin
    Omidkhoda, Navid
    Karimi, Gholamreza
    CELL CYCLE, 2023, 22 (07) : 741 - 757
  • [29] Troxerutin Protects Against Myocardial Ischemia/Reperfusion Injury Via Pi3k/Akt Pathway in Rats
    Shu, Liliang
    Zhang, Wanzhe
    Huang, Chen
    Huang, Gongcheng
    Su, Gang
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 44 (05) : 1939 - 1948
  • [30] PI3K/AKT pathway: A potential therapeutic target in cerebral ischemia-reperfusion injury
    Han, Yiming
    Sun, Yu
    Peng, Shiyu
    Tang, Tingting
    Zhang, Beibei
    Yu, Ruonan
    Sun, Xiaoyan
    Guo, Shanshan
    Ma, Lijuan
    Li, Peng
    Yang, Pengfei
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 998